Insights
Understanding gene-based interventions: gene therapy vs gene editing
Estimated read time 5 min
Advances in genetic science are opening new possibilities in how we understand and treat disease. Among the most talked-about developments are gene therapy and gene editing - two approaches that hold the potential to modify, and potentially even cure, diseases by targeting their genetic roots.
Insights
Repurposing existing medicines can expedite drug development
Estimated read time 6 min
The development of new medicines is an expensive and time-consuming process, so pharmaceutical companies need deep pockets and huge resources to see potential new treatments through to marketing authorisation.
Insights
Treatment regimens are changing: patients are benefiting from home-based therapies and low-frequency administration
Estimated read time 6 min
In recent years, the healthcare landscape has been steadily moving towards more patient-centric models, focusing on convenience and quality of life.
Insights
Can we afford future cell and gene therapies? Payer perspectives on sustainable reimbursement
Estimated read time 22 min
As an increasing number of Advanced Therapy Medicinal Products (ATMPs), including CGTs, are seeking market authorisation, the growing costs of these therapies need to be managed by payers to ensure long-term access for patients in need.
